A research-grade peptide programme operating outside the convention of the inflated retail catalogue. Each compound is third-party assayed, lot-traced, and supplied for laboratory use against a transparent margin.
Specific compounds, lot data, and certificates of analysis are published with the catalogue at distribution. The classes below describe the breadth of the initial release.
Multi-receptor metabolic compounds combining incretin and glucagon agonism, prepared for comparative pharmacology and energy-metabolism research.
Single-target research peptides for receptor isolation, signalling-pathway characterisation, and selective comparative work against blended agents.
Copper-peptide and tripeptide raw material for dermatological, regenerative, and topical formulation research.
Neuroactive and neurotrophic peptides for cognitive, behavioural, and central-nervous-system pharmacology applications.
Enrolment grants priority notice on catalogue release, lot dispatch, and limited-quantity research compounds. The list closes at distribution.